IP Library › Granted Patent US 10,383,818
Granted Patent B2
US 10,383,818 · App. 15/363,372 · Granted Aug 20, 2019

Emulsion

Inventors: Ingvild Haug (Trondheim, NO); Kurt Ingar Draget (Trondheim, NO)
Assignee: VITUX GROUP AS
A61K9/0056A23G4/066A23L29/281A23L33/115A61K9/107A61K31/167A61K47/26A61K47/36A61K47/42A61K47/44B65D75/327A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,383,818
App. No.
15/363,372
Granted
Aug 20, 2019
Kind
B2
Abstract

The invention relates to an orally administrable chewable composition in unit dosage form comprising an oil-in-water emulsion in which the aqueous phase is gelled and in which the oil phase comprises a physiologically tolerable unsaturated fatty acid ester.

Claims (14)

1. An orally administrable chewable composition in unit dosage form comprising a chewable, set oil-in-water emulsion in which the aqueous phase is gelled and constitutes about 50% to 60% wt. of the unit dosage form, wherein said aqueous phase comprises gelatin in an amount of about 10% to 25% wt. of the aqueous phase and wherein the oil phase comprises a physiologically tolerable omega-3 or omega-6 fatty acid ester and constitutes about 40% of the dose unit, and wherein the unit dosage form has an overall dose unit weight of 0.25 to 3 g, and wherein the composition, upon chewing, remains free of bad odor and taste.

2. The composition as claimed in claim 1 , wherein the omega-3 or omega-6 fatty acid ester is a physiologically tolerable triglyceride.

3. The composition as claimed in claim 1 , wherein the omega-3 or omega-6 fatty acid ester is a fish oil.

4. The composition as claimed in claim 1 , wherein said aqueous phase further comprises polysaccharides.

5. The composition as claimed in claim 1 , wherein said aqueous phase further comprises carageenan.

6. The composition as claimed in claim 1 , further comprising at least 1% wt. xylitol.

7. The composition as claimed in claim 1 , further comprising a citrus flavor.

8. The composition as claimed in claim 1 , wherein said aqueous phase further comprises a water soluble vitamin.

9. The composition as claimed in claim 1 in animal, doll, vehicle, rod, strip or tube shape.

10. A package comprising an air-tight compartment containing one dose unit of a composition as claimed in claim 1 .

11. The package as claimed in claim 10 in the form of a blister pack.

12. A method of treatment of a human by oral administration of an effective amount of an active agent in oil form or dissolved in an oil comprising administering said active agent in a chewable composition according to claim 1 .

13. The method as claimed in claim 12 , wherein said active agent is an analgesic.

14. The method as claimed in claim 12 , wherein said active agent is a triglyceride.

Assignments (2)
CHANGE OF NAME Recorded Apr 5, 2017
From: AYANDA GROUP AS
To: VITUX GROUP AS
Reel/Frame 042168/0635 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2016
From: HAUG, INGVILD; DRAGET, KURT INGAR
To: AYANDA GROUP AS
Reel/Frame 040495/0665 →
Priority Claims (1)
GB 0601498.9 · Jan 25, 2006 · national
Continuity (2)
Continuation 12162339
Related Publication 20170071854A1 · Mar 16, 2017